Skip to main content

Most Recent

Clipboard with charts: HPV statistics

HPV statistics 2024

An estimated 85% of people will get an HPV infection in their lifetime
asthma inhaler - Flovent discontinued

Flovent discontinued

The go-to asthma treatment has been replaced by an authorized generic
Three cellphones showing charts and graphs: HIV stats

HIV statistics 2024

Globally, people who inject drugs have 35 times the risk of acquiring HIV of the general population, female sex workers have 30 times the risk, gay men have 28 times the risk, and transgender women have 14 times the risk
Statistical charts on a clipboard: Herpes statistics

Herpes statistics 2024

Globally, around half a billion people have genital herpes, and several billion have oral herpes
FDA Approval Stamp - Zepbound

FDA approves Zepbound

This prescription is a version of Mounjaro, which is only approved for Type 2 diabetes
FDA Approval Stamp - Wezlana

FDA approves Wezlana

This medication is a biosimilar—like a generic for biologic medications—for the popular drug Stelara
FDA approval stamp - Januvia

FDA approves Zituvio for diabetes

This new medication joins Januvia and Janumet on the market
Statistical charts on a clipboard: Breast cancer statistics

Breast cancer statistics 2024

Breast cancer accounts for almost 30% of new female cancers each year. Learn more here.
Clipboard holding sheet with charts: Cancer statistics

Cancer statistics 2024

Breast cancer is the most common type of cancer in the U.S.
Three smartphones showing graphs and charts: Weight loss statistics

Weight loss statistics 2024

One-third of people living in the U.S. have obesity, and 50-70% wish to engage in a weight loss program
Over-the-counter birth control FDA approved

FDA approves OTC birth control pills

This historic approval of Opill could expand contraceptive access to millions of people